Author:
Foster Graham R.,Zeuzem Stefan,Andreone Pietro,Pol Stanislas,Lawitz Eric J.,Diago Moises,Roberts Stuart,Pockros Paul J.,Younossi Zobair,Lonjon-Domanec Isabelle,De Meyer Sandra,Luo Don,George Shelley,Beumont Maria,Picchio Gaston
Reference27 articles.
1. Monitoring of viral levels during therapy of hepatitis C;Davis;Hepatology,2002
2. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection;McHutchison;N Engl J Med,2009
3. INCIVEK® (telaprevir) tablets. FDA prescribing information May 2011. Available from: http://pi.vrtx.com/files/uspi_telaprevir.pdf [Accessed 19 December 2011].
4. European Medicines Agency. INCIVO® (telaprevir) tablets. Summary of product characteristics October 2011. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002313/WC500115529.pdf [Accessed 19 December 2011].
5. VICTRELIS® (boceprevir) capsules. FDA prescribing information May 2011. Available from: http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf [Accessed 19 December 2011].
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献